Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study. (Record no. 22327182)

MARC details
000 -LEADER
fixed length control field 01757 a2200457 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516124025.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201306s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1095-6859
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.ygyno.2012.11.038
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Monk, Bradley J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20130624
245 00 - TITLE STATEMENT
Title Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Gynecologic oncology
Date of publication, distribution, etc. Mar 2013
300 ## - PHYSICAL DESCRIPTION
Extent 573-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bevacizumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carboplatin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Maintenance Chemotherapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ovarian Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Paclitaxel
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Placebos
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quality of Life
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Huang, Helen Q
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Burger, Robert A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mannel, Robert S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Homesley, Howard D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fowler, Jeffrey
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Greer, Benjamin E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Boente, Matthew
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Liang, Sharon X
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wenzel, Lari
773 0# - HOST ITEM ENTRY
Title Gynecologic oncology
Related parts vol. 128
-- no. 3
-- p. 573-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.ygyno.2012.11.038">https://doi.org/10.1016/j.ygyno.2012.11.038</a>
Public note Available from publisher's website

No items available.